Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-20-187869
Filing Date
2020-07-06
Accepted
2020-07-06 16:29:52
Documents
1
Group Members
ATHYRIUM CAPITAL HOLDINGS, LLCATHYRIUM FUNDS GP HOLDINGS LLCATHYRIUM OPPORTUNITIES 2020 LPATHYRIUM OPPORTUNITIES ADVISERS LLCATHYRIUM OPPORTUNITIES ASSOCIATES CO-INVEST LLCATHYRIUM OPPORTUNITIES ASSOCIATES GP LLCATHYRIUM OPPORTUNITIES ASSOCIATES III GP LL

Document Format Files

Seq Description Document Type Size
1 SC 13D d944130dsc13d.htm SC 13D 376372
  Complete submission text file 0001193125-20-187869.txt   378847
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
PROGENITY, INC. (Subject) CIK: 0001580063 (see all company filings)

EIN.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91551 | Film No.: 201013818
SIC: 8071 Services-Medical Laboratories

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 212-402-6925
Athyrium Capital Management, LP (Filed by) CIK: 0001728001 (see all company filings)

EIN.: 263965190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D